Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:endDate |
2013
|
| gptkbp:enrollment |
2504
|
| gptkbp:fullName |
HIV Vaccine Trials Network 505 trial
|
| gptkbp:intervention |
DNA/rAd5 HIV-1 vaccine
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:period |
Phase IIb
|
| gptkbp:population |
gptkb:men_who_have_sex_with_men
transgender women |
| gptkbp:principalInvestigator |
Scott Hammer
|
| gptkbp:reasonForStopping |
futility
|
| gptkbp:recognizedBy |
NCT00865566
|
| gptkbp:result |
did not prevent HIV infection
did not reduce viral load |
| gptkbp:sponsor |
gptkb:National_Institute_of_Allergy_and_Infectious_Diseases
|
| gptkbp:startDate |
2009
|
| gptkbp:studiedBy |
HIV vaccine
|
| gptkbp:trialStopped |
2013
|
| gptkbp:bfsParent |
gptkb:Jeanne_Marie_Ryan
|
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
HVTN 505 trial
|